Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Family Dollar Sees 'Virtual Certainty' Of Antitrust Clearance For Dollar Tree Merger also written by Antoine Gara
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
- No Sleep Till Activism: Hedge Fund H Partners Wins Mattress Company Fight also written by Antoine Gara
- Comcast Boosts Stock Buyback Nearly 60% After Time Warner Cable Deal Bust also written by Antoine Gara
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
Login to comment.